FCER1G and Alzheimer disease: Tyrobp and Fcer1g was found to be differentially expressed in Alzheimer’s disease (AD) mouse models that demonstrated strong correlation between cortical Aβ amyloidosis and the neuroinflammatory response (Castillo et al., 2017).